Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cyclerion Therapeutics (CYCN) Interest & Investment Income (2019 - 2020)

Historic Interest & Investment Income for Cyclerion Therapeutics (CYCN) over the last 2 years, with Q4 2020 value amounting to -$4000.0.

  • Cyclerion Therapeutics' Interest & Investment Income fell 10075.33% to -$4000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $588000.0, marking a year-over-year change of. This contributed to the annual value of $588000.0 for FY2020, which is 7102.02% down from last year.
  • As of Q4 2020, Cyclerion Therapeutics' Interest & Investment Income stood at -$4000.0, which was down 10075.33% from $93000.0 recorded in Q3 2020.
  • Cyclerion Therapeutics' 5-year Interest & Investment Income high stood at $800000.0 for Q2 2019, and its period low was -$4000.0 during Q4 2020.